Find uplifting stories about heroes, innovations, and solutions
8028 results for "lung cancer treatment"
A powerful new combination therapy just gained approval to help patients fighting an aggressive form of lung cancer live longer. The treatment offers hope for thousands diagnosed with extensive-stage small cell lung cancer each year.
A new targeted therapy for a rare form of lung cancer just earned priority review from the FDA, potentially offering hope to thousands of patients who currently have limited treatment options. The drug specifically targets HER2 mutations found in about 2-4% of lung cancer cases.
A groundbreaking cancer treatment just gave patients with hard-to-treat lung cancer something they desperately needed: hope. Chinese biotech company Akeso's new drug ivonescimab beat the current standard treatment in a major clinical trial, marking a historic win for patients with limited options.
New targeted therapies and immunotherapies for lung cancer are now reaching over 60% of patients with advanced disease, a dramatic improvement in treatment access. Fifteen states have enacted laws requiring insurance coverage for biomarker testing that helps match patients to lifesaving treatments.
Multiple research teams discovered that aggressive lung cancer cells form actual connections with brain neurons, and drugs that block these connections slow tumor growth in mice. The breakthrough could lead to new treatment options for one of the deadliest cancers.
Two new therapies just won backing from European regulators to treat one of the deadliest forms of lung cancer. The treatments fill critical gaps that have frustrated doctors for decades.
Researchers analyzed real-world data from 940 patients to compare five lung cancer drugs, finding clearer answers about which treatments work best. The findings could help doctors and patients make smarter decisions about care.
A groundbreaking study from China reveals that lung cancer patients who receive immunochemotherapy before 3pm survive nearly twice as long. The discovery could transform treatment timing at no extra cost.
A promising new pill shrank tumors in nearly two-thirds of lung cancer patients and 40% of pancreatic cancer patients in early trials. The results exceeded expectations and could offer fresh hope for people facing these difficult diagnoses.
A groundbreaking cancer treatment just showed remarkable results that exceeded doctors' expectations in treating one of the deadliest forms of lung cancer. The drug ivonescimab reduced the risk of death by 34% compared to standard treatment for patients with squamous non-small cell lung cancer.
Mayo Clinic researchers discovered that brigatinib, a lung cancer drug, may help ovarian cancer patients overcome treatment resistance when combined with existing therapies. The breakthrough could transform care for women facing one of the deadliest cancers.
A new pill targeting aggressive pancreatic and lung cancers showed remarkable results in early trials, shrinking tumors in nearly two-thirds of lung cancer patients. The therapy offers fresh hope for patients facing some of the deadliest cancer diagnoses.
Two newly approved cancer treatments are giving Scottish patients hope, with one lung cancer drug reducing disease progression by 84%. The drugs offer patients more choices and better outcomes in their fight against cancer.
Researchers discovered why some lung cancer cells resist treatment and found a natural compound that could help. The breakthrough reveals a "bodyguard system" that protects cancer cells and a way to shut it down.
A breakthrough cancer treatment helped patients with advanced lung cancer live over four months longer than current therapies. The experimental drug reduced the risk of death by 34% in a study of 532 patients.
A breakthrough study shows lung cancer patients who received treatment before 3 p.m. lived nearly twice as long as those treated later in the day. This simple scheduling change could transform cancer care without adding any cost.
A New York grandmother is cancer-free after receiving proton therapy, a precise radiation treatment that spared her from typical side effects. Marie Francillion never smoked but developed lung cancer that spread to her lymph nodes in 2022.
A new combination drug therapy reduced lung cancer progression by 65% in a groundbreaking study, offering fresh hope for patients facing this deadly disease. The treatment marks the first successful pairing of two powerful cancer-fighting approaches in previously untreated patients.
A groundbreaking $4 million clinical trial in Canada is pairing gut bacteria capsules with immunotherapy to help lung cancer patients who aren't responding to standard treatments. If successful, the LUNA-2 trial could extend lives and reduce side effects for thousands of Canadians.
A promising new lung cancer treatment called Pumitamig is giving hope to patients with advanced disease, showing a 70% response rate regardless of their PD-L1 status. The breakthrough was announced at the 2026 ASCO conference, one of the world's leading cancer research gatherings.
Showing 20 of 8028